Priya Chandra

646 total citations
8 papers, 525 citations indexed

About

Priya Chandra is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Priya Chandra has authored 8 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Priya Chandra's work include Heart Failure Treatment and Management (2 papers), Genetic Neurodegenerative Diseases (2 papers) and Retinal Development and Disorders (1 paper). Priya Chandra is often cited by papers focused on Heart Failure Treatment and Management (2 papers), Genetic Neurodegenerative Diseases (2 papers) and Retinal Development and Disorders (1 paper). Priya Chandra collaborates with scholars based in United States, Switzerland and Russia. Priya Chandra's co-authors include Jessie Gu, William P. Dole, Arco Y. Jeng, R. Sarangapani, Adele Noè, Gary M. Ksander, Dean F. Rigel, Suzanne Maahs, Tsu‐Han Lin and Monica Ligueros‐Saylan and has published in prestigious journals such as Neurology, Journal of Hepatology and American Journal of Ophthalmology.

In The Last Decade

Priya Chandra

8 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priya Chandra United States 6 413 106 102 70 30 8 525
Vittoria Mastromarino Italy 14 520 1.3× 78 0.7× 79 0.8× 90 1.3× 44 1.5× 27 708
Vijay Ramu United States 7 217 0.5× 50 0.5× 57 0.6× 176 2.5× 43 1.4× 30 443
Frida Liane Plavnik Brazil 13 256 0.6× 33 0.3× 79 0.8× 44 0.6× 33 1.1× 41 403
Hiromi Gotou Japan 9 400 1.0× 85 0.8× 194 1.9× 51 0.7× 11 0.4× 13 510
Seiko Manabe Japan 11 252 0.6× 95 0.9× 108 1.1× 40 0.6× 46 1.5× 14 472
Jwari Ahn United States 10 332 0.8× 42 0.4× 166 1.6× 82 1.2× 51 1.7× 10 534
Csaba András Dézsi Hungary 13 290 0.7× 38 0.4× 62 0.6× 53 0.8× 21 0.7× 38 487
Hiroaki Mukawa Japan 11 221 0.5× 57 0.5× 49 0.5× 61 0.9× 44 1.5× 17 389
Ewald Kolesnik Austria 13 203 0.5× 47 0.4× 176 1.7× 136 1.9× 39 1.3× 54 463

Countries citing papers authored by Priya Chandra

Since Specialization
Citations

This map shows the geographic impact of Priya Chandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priya Chandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priya Chandra more than expected).

Fields of papers citing papers by Priya Chandra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priya Chandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priya Chandra. The network helps show where Priya Chandra may publish in the future.

Co-authorship network of co-authors of Priya Chandra

This figure shows the co-authorship network connecting the top 25 collaborators of Priya Chandra. A scholar is included among the top collaborators of Priya Chandra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priya Chandra. Priya Chandra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
3.
Wykoff, Charles C., Vrinda Hershberger, David Eichenbaum, et al.. (2021). Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results. American Journal of Ophthalmology. 235. 131–142. 20 indexed citations
4.
Eichenbaum, David, Charles C. Wykoff, Vrinda Hershberger, et al.. (2021). Inhibition of complement C3 in geographic atrophy with NGM621: Phase 1 study results. 62(8). 1214–1214. 2 indexed citations
5.
Kerchner, Geoffrey A., Gai Ayalon, Flávia Brunstein, et al.. (2017). [O2–17–03]: A PHASE I STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF RO7105705 IN HEALTHY VOLUNTEERS AND PATIENTS WITH MILD‐TO‐MODERATE AD. Alzheimer s & Dementia. 13(7S_Part_12). 10 indexed citations
6.
Kotovskaya, Yu. V., О. В. Аверков, Е.П. Павликова, et al.. (2016). Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction. Cardiovascular Therapeutics. 34(4). 191–198. 66 indexed citations
7.
Gu, Jessie, Adele Noè, Priya Chandra, et al.. (2009). Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi). The Journal of Clinical Pharmacology. 50(4). 401–414. 406 indexed citations
8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026